| Targeting glioblastoma stem cells through disruption of the circadian clock Z Dong, G Zhang, M Qu, RC Gimple, Q Wu, Z Qiu, BC Prager, X Wang, ... Cancer discovery 9 (11), 1556-1573, 2019 | 194 | 2019 |
| Nuclear receptor HNF4A transrepresses CLOCK: BMAL1 and modulates tissue-specific circadian networks M Qu, T Duffy, T Hirota, SA Kay Proceedings of the National Academy of Sciences 115 (52), E12305-E12312, 2018 | 79 | 2018 |
| Clocking cancer: the circadian clock as a target in cancer therapy F Battaglin, P Chan, Y Pan, S Soni, M Qu, ER Spiller, S Castanon, ... Oncogene 40 (18), 3187-3200, 2021 | 55 | 2021 |
| Circadian regulator BMAL1:: CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle M Qu, G Zhang, H Qu, A Vu, R Wu, H Tsukamoto, Z Jia, W Huang, ... Proceedings of the National Academy of Sciences 120 (2), e2214829120, 2023 | 42 | 2023 |
| HNF4A defines tissue-specific circadian rhythms by beaconing BMAL1:: CLOCK chromatin binding and shaping the rhythmic chromatin landscape M Qu, H Qu, Z Jia, SA Kay Nature communications 12 (1), 6350, 2021 | 37 | 2021 |
| Phosphorylation-dependent assembly and coordination of the DNA damage checkpoint apparatus by Rad4TopBP1 M Qu, M Rappas, CP Wardlaw, V Garcia, JY Ren, M Day, AM Carr, ... Molecular cell 51 (6), 723-736, 2013 | 34 | 2013 |
| Phosphorylation-dependent interactions between Crb2 and Chk1 are essential for DNA damage checkpoint M Qu, B Yang, L Tao, JR Yates III, P Russell, MQ Dong, LL Du PLoS genetics 8 (7), e1002817, 2012 | 29 | 2012 |
| The actin cytoskeleton-MRTF/SRF cascade transduces cellular physical niche cues to entrain the circadian clock X Xiong, W Li, J Nam, M Qu, SA Kay, K Ma Journal of Cell Science 135 (19), jcs260094, 2022 | 13 | 2022 |
| Molecular crosstalk between circadian clock and cancer and therapeutic implications M Qu Frontiers in Nutrition 10, 1143001, 2023 | 3 | 2023 |
| Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis Y Wang, R Narasimamurthy, M Qu, N Shi, H Guo, Y Xue, N Barker Nature cancer, 1-11, 2024 | | 2024 |
| Targeting the clock pathway to modulate immune response in MSI-high colorectal cancer (CRC): evidence from a preclinical in vivo model S Soni, F Battaglin, S Castanon, JH Lo, G Smbatyan, P Chan, M Qu, ... Cancer Research 83 (7_Supplement), 4124-4124, 2023 | | 2023 |
| IIIandMe: An Algorithm for Chromosome-scale Haplotype Determination Using Genome-wide Variants of Three Haploid Reproductive Cells H Qu, R Li, L Yu, W Chen, Y Feng, Q Jia, R Traband, X Wang, S Wang, ... bioRxiv, 2022.12. 07.519546, 2022 | | 2022 |
| Differential Expression Analysis: Simple Pair, Interaction, Time-series H Qu, M Qu, S Wang, L Yu, Q Jia, X Wang, Z Jia | | 2022 |
| OMRT-14. Small molecule circadian clock compounds exhibit potential as a novel therapy paradigm for glioblastoma P Chan, T Hirota, M Qu, G Zhang, K Shah, H Wakimoto, T Kamenecka, ... Neuro-oncology Advances 3 (Suppl 2), ii9, 2021 | | 2021 |
Steve A KayUniversity of Southern California在 usc.edu 的电子邮件经过验证
